Mengjun Huang

Shenzhen, 518107, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

PARP1-mediated PARylation of TEAD4 stabilizes the YAP1-TEAD4 complex and promotes growth and immune evasion in breast cancer cells.

PARP1-mediated PARylation of TEAD4 stabilizes the YAP1-TEAD4 complex and promotes growth and immune evasion in breast cancer cells.

Journal: Science signaling

Published: October 21, 2025

CDK12-Mediated Phosphorylation of FOXA1 Promotes Prostate Cancer Progression via the MDM2-p53 Axis.

CDK12-Mediated Phosphorylation of FOXA1 Promotes Prostate Cancer Progression via the MDM2-p53 Axis.

Journal: Research (Washington, D.C.)

Published: May 04, 2025

CDK12 Inactivation Attenuates Prostate Cancer Progression by Inhibiting BNIP3-Mediated Mitophagy.

CDK12 Inactivation Attenuates Prostate Cancer Progression by Inhibiting BNIP3-Mediated Mitophagy.

Journal: Cell proliferation

Published: March 04, 2025

A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancer.

A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancer.

Journal: Journal of health, population, and nutrition

Published: February 27, 2025

HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.

HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.

Journal: Oncogene

Published: February 13, 2025

Nop2/Sun domain family member 5 contributes to tumorigenic properties in prostate cancer by engaging the PI3K-AKT pathway and tumor-associated macrophages.

Nop2/Sun domain family member 5 contributes to tumorigenic properties in prostate cancer by engaging the PI3K-AKT pathway and tumor-associated macrophages.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 17, 2025

TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy.

TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: November 26, 2024

Causal relationships between plasma metabolites and prostate cancer: A Mendelian randomization study exploring immune and inflammatory mediators.

Causal relationships between plasma metabolites and prostate cancer: A Mendelian randomization study exploring immune and inflammatory mediators.

Journal: Current urology

Published: October 12, 2024

Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer.

Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer.

Journal: Biomaterials science

Published: February 21, 2024

Hippo signaling modulation and its biological implications in urological malignancies.

Hippo signaling modulation and its biological implications in urological malignancies.

Journal: Molecular aspects of medicine

Published: December 19, 2023

Showing 1-10 of 10

Last Updated: 09/26/2026